National

317 COVID cases for Friday

Darpan News Desk The Canadian Press, 28 May, 2021 03:50 PM

As we wrap up the work week, some great news heading into the weekend. The seven-day average is now 315 new cases per day, the lowest since November 2.

There are 317 new COVID cases today, for a total of 143,581 cases in British Columbia.

There are 3,441 active cases of COVID-19 in the province, and a further 138,360 people who tested positive have recovered.

New cases by health authority Vancouver Coastal Health - 73 Fraser Health - 163 Island - 5 Interior - 60 Northern - 16

There are 292 individuals currently hospitalized with COVID-19, 79 of whom are in intensive care.

There have been 2 new COVID-19 related deaths, for a total of 1,692 deaths in British Columbia.

3,106,269 doses of Pfizer-BioNTech, Moderna and AstraZeneca COVID-19 vaccines have been administered in B.C., 160,885 of which are second doses.

Right now 67.2% of all adults in B.C. and 62.7% of those aged 12 and older have received at at least a first dose of a COVID-19 vaccine.

Prev Next

MORE National ARTICLES

Microsoft Canada expanding in Vancouver

“The expansion of Microsoft’s cloud services and its investment in building applications further establishes the Lower Mainland as a growing hub for technology and innovation“.

Microsoft Canada expanding in Vancouver

Tourism workers to help with B.C. vaccinations

Premier John Horgan says the province has partnered with 14 hard-hit businesses across the province to help get some of their employees back to work.

Tourism workers to help with B.C. vaccinations

Canada downplays new EU COVID vaccine measures

European sources said Canadian shipments require an export authorization but those should be granted as long as they don’t pose a threat to domestic supply.

Canada downplays new EU COVID vaccine measures

Industry minister foresees biotech revival

Prime Minister Justin Trudeau announced last month that Canada has a new contract with Maryland-based Novavax to eventually churn out doses of its vaccine at a new National Research Council facility going up in Montreal.